bn:02537547n
Noun Concept
Categories: Tyrosine kinase inhibitors, Quinolines, Multiple chemicals in Infobox drug, Breakthrough therapy, Orphan drugs
EN
cabozantinib  Cabozantinib s-malate  BMS-907351  BMS907351  BMS 907351
EN
Cabozantinib, sold under the brand names Cometriq and Cabometyx among others, is an anti-cancer medication used to treat medullary thyroid cancer, renal cell carcinoma, and hepatocellular carcinoma. Wikipedia
Definitions
Relations
Sources
EN
Cabozantinib, sold under the brand names Cometriq and Cabometyx among others, is an anti-cancer medication used to treat medullary thyroid cancer, renal cell carcinoma, and hepatocellular carcinoma. Wikipedia
Chemical compound Wikidata